key: cord-0729391-p1nm32ds authors: Chan, Chloe Toi-Mei; Leung, Jake Siu-Lun; Lee, Lam-Kwong; Lo, Hazel Wing-Hei; Wong, Evelyn Yin-Kwan; Wong, Denise Sze-Hang; Ng, Timothy Ting-Leung; Lao, Hiu-Yin; Lu, Kelvin Keru; Jim, Stephanie Hoi-Ching; Yau, Miranda Chong-Yee; Lam, Jimmy Yiu-Wing; Ho, Alex Yat-Man; Luk, Kristine Shik; Yip, Kam-Tong; Que, Tak-Lun; To, Kelvin Kai-Wang; Siu, Gilman Kit-Hang title: A low-cost TaqMan minor groove binder probe-based one-step RT-qPCR assay for rapid identification of N501Y variants of SARS-CoV-2 date: 2021-10-14 journal: J Virol Methods DOI: 10.1016/j.jviromet.2021.114333 sha: cb71e97b6195bc40576c59a3b55623b6525af23e doc_id: 729391 cord_uid: p1nm32ds The increasing prevalence of N501Y variants of SARS-CoV-2 has kindled global concern due to their enhanced transmissibility. Genome sequencing is the gold standard method to identify the emerging variants of concern. But it is time-consuming and expensive, limiting the widespread deployment of genome surveillance in some countries. Health authorities surge the development of alternative assay to expand screening capacity with reduced time and cost. In this study, we developed an in-house TaqMan minor groove binder (MGB) probe-based one-step RT-qPCR assay to detect the presence of N501Y mutation in SARS-CoV-2. A total of 168 SARS-CoV-2 positive respiratory specimens were collected to determine diagnostic accuracy of the RT-qPCR assay. As a reference standard, PANGO lineages and the mutation patterns of all samples were characterised by whole-genome sequencing. The analytical sensitivity and the ability of the assay to detect low frequency of N501Y variants were also evaluated. A total of 31 PANGO lineages were identified from 168 SARS-CoV-2 positive cases, in which 34 samples belonged to N501Y variants, including B.1.1.7 (n = 20), B.1.351 (n = 12) and P.3 (n = 2). The N501Y RT-qPCR correctly identified all 34 samples as N501Y-positive and the other 134 samples as wildtype. The limit-of-detection of the assay consistently achieved 1.5 copies/μL on four different qPCR platforms. N501Y mutation was successfully detected at an allele frequency as low as 10% in a sample with mixed SARS-CoV-2 lineage. The N501Y RT-qPCR is simple and inexpensive (US$1.6 per sample). It enables robust high-throughput screening for surveillance of SARS-CoV-2 variants of concern harbouring N501Y mutation. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. this study, we developed an in-house TaqMan minor groove binder (MGB) probe-based onestep RT-qPCR assay to detect the presence of N501Y mutation in SARS-CoV-2. A total of 168 SARS-CoV-2 positive respiratory specimens were collected to determine diagnostic accuracy of the RT-qPCR assay. As a reference standard, PANGO lineages and the mutation patterns of all samples were characterised by whole-genome sequencing. The analytical sensitivity and the ability of the assay to detect low frequency of N501Y variants were also evaluated. A total of 31 PANGO lineages were identified from 168 SARS-CoV-2 positive cases, in which 34 samples belonged to N501Y variants, including B.1.1.7 (n=20), B.1.351 (n=12) and P.3 (n=2). The N501Y RT-qPCR correctly identified all 34 samples as N501Y-positive and the other 134 samples as wildtype. The limit-of-detection of the assay consistently achieved 1.5 copies/μL on four different qPCR platforms. N501Y mutation was successfully detected at an allele frequency as low as 10% in a sample with mixed SARS-CoV-2 lineage. The N501Y RT-qPCR is simple and inexpensive (US$1.6 per sample). It enables robust highthroughput screening for surveillance of SARS-CoV-2 variants of concern harbouring N501Y mutation. Keywords: COVID-19, SARS-CoV-2, variant of concern, N501Y variants, one-step RT-qPCR November 2020 has rapidly become the predominant strain across the country [1] . Their highly mutated spike glycoprotein, especially the N501Y substitution, has been shown to enhance viral entry into the host cell [2] [3] [4] . The N501Y mutation is also observed in other SARS-CoV-2 variants of concern, including B.1.351 and P.1, where a similar sharp increase in spread and frequency of the virus was noticed in their respective area of origin [5, 6] . The increasing prevalence of N501Y containing variants has kindled global concern due to their heightened transmissibility [2] and their potential to evade host immune responses [7, 8] and cause reinfection [9] . Currently, whole genome sequencing (WGS) is the gold standard method to differentiate and identify different emerging variants of SARS-CoV-2. However, the application of genome surveillance might not be widely deployed in some countries because it is a relatively time-consuming and expensive approach to screen all SARS-CoV-2 positive samples to detect relevant mutation, where result delivery will take at least 3-4 days. As N501Y has started to dominate the current circulating viral population in Asia [10] , health authorities surge the development of alternative assay to expand screening capacity with reduced time and cost. In this study, we present an in-house developed TaqMan MGB (minor groove binder) probe-based one-step RT-qPCR assay to detect the presence of N501Y mutation in SARS-CoV-2 positive specimens, providing analytical sensitivity as low as 1.5 copies/μL and result delivery within 40 minutes. Unlike other commercial assays, which are only compatible with certain qPCR platforms, our assay can be conducted on a wide range of qPCR instruments with identical analytical performance. instructions. The PANGO lineages, nucleotide mutation and amino acid substitution patterns of SARS-CoV-2 were characterised by whole genome sequencing using Nanopore MinION as described previously [11, 12] . All sequences are available on the NCBI Genbank under the accession numbers MZ266365 -MZ267539. (ddPCR) Kit (BIO-RAD, US) and were normalized to 1,500 copies/μL respectively, followed by serially diluted down to 0.15 copies/μL. Both sets of dilutions were tested with the optimized RT-qPCR protocol in 10 replicates on four different qPCR platforms. All platforms could consistently identify N501Y variant at a concentration as low as 1.5 copies/μL, which was therefore considered as the limit of detection (LoD) of the assay (Figure 1 ). In addition, the ability of our assay to identify low-frequency N501Y variants was evaluated by mixing B.1.1.7 SARS-CoV-2 RNA with B.1.36.27 SARS-CoV-2 RNA at ratios from 9:1 (allele frequency = 90%) to 1:9 (allele frequency =10%). Interestingly, N501Y mutation was successfully detected at an allele frequency as low as 10% in the RNA mixtures (Figure 1 ). Regarding the diagnostic accuracy, the RT-qPCR results were in 100% agreement with the WGS data, where all 34 samples were correctly identified as N501Y-positive, and the other 134 samples were indicated as wildtype. N501Y was accurately discriminated regardless of the lineages of SARS-CoV-2 (Table S1, Supplemental Material). N501Y mutation is a surrogate marker of SARS-CoV-2 variants of concern, including lineages Furthermore, our assay uses MGB probes that can offer better sequence specificity, especially when targeting single base mismatches, than standard DNA probes via the formation of stable probe-target duplex during hybridization using shorter probe sequences. In this study, we developed an in-house TaqMan MGB probe-based one-step RT-qPCR assay that can specifically and accurately detect the N501Y containing variants in SARS-CoV-2 positive samples. The reagent cost per sample is around US$ 1.6, which is at least 7-fold less than the commercial assays. The LoD of our assay is as low as 1.5 copies/μL (i.e. 3 copies/reaction) and is capable of detecting minor N501Y variant at 10% frequency. The evaluation study demonstrated that our RT-qPCR achieved diagnostic sensitivity and specificity of 100% in comparison to WGS result as a reference. Our assay also offers compatibility with a wide range of common qPCR platforms. The major limitation of the assay is its inability to detect the recently expanding SARS-CoV-2 variant of concern, B.1.617.2 lineage, (a.k.a G/452R.V3), which does not harbour N501Y mutation but E484Q and L452R instead. Our laboratory is developing another TaqMan MGB probe-based one-step RT-qPCR assay to detect the presence of L452R mutation, which shall be used in conjunction with N501Y RT-qPCR. Combined use of these two RT-qPCR assays should be able to detect all reported variants of concern. J o u r n a l P r e -p r o o f . The LoD of this assay was determined as 1.5 copies/µL for both N501 and Y501 alleles. (1G) Wildtype and N501Y containing SARS-CoV-2 RNA were mixed at ratios from 9:1 (allele frequency = 90%) to 1:9 (allele frequency =10%). (1H, 1I) Amplification curves of mutant: wildtype RNA mixtures. N501Y mutation was successfully detected at an allele frequency as low as 10% in the RNA mixtures. In conclusion, the N501Y RT-qPCR can be rapidly implemented and widely adopted by clinical laboratories as it is simple and inexpensive to run robust high-throughput screening for surveillance of SARS-CoV-2 variants of concern harbouring N501Y mutation Conceptualization, Methodology, Investigation, Validation, Writing -Original Draft, Writing -Review & Editing Conceptualization, Methodology, Investigation, Validation, Writing -Original Draft, Writing -Review & Editing Methodology, Validation, Investigation, Writing -Review & Editing Hazel Wing-Hei LO: Methodology, Validation, Investigation, Writing -Review & Editing Evelyn Yin-Kwan WONG: Methodology, Validation, Writing -Review & Editing Denise Sze-Hang WONG: Validation, Writing -Review & Editing Timothy Ting-Leung NG: Conceptualization, Data Curation, Writing -Review & Editing Hiu-Yin LAO: Validation, Investigation, Writing -Review & Editing Kelvin Keru LU: Formal analysis, Writing -Review & Editing Stephanie Hoi-Ching JIM: Validation, Writing -Review & Editing Miranda Chong-Yee YAU: Data Curation, Resources Data Curation, Resources, Formal analysis Kristine Shik LUK: Supervision, Data Curation, Resources Data Curation, Resources, Formal analysis Tak-Lun QUE: Supervision, Data Curation, Resources Conceptualization, Methodology, Validation, Formal analysis, Project administration, Funding acquisition, Writing -Original Draft Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England The N501Y spike substitution enhances SARS-CoV-2 transmission. bioRxiv Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01 Clade and lineage nomenclature aids in genomic epidemiology studies of active hCoV-19 viruses A Territory-Wide Study of Early Coronavirus Disease Outbreak Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong? Research on COVID-19 (COVID190204) and the Innovation and Technology Fund -Innovation and Technology Support Programme -Public Sector Trial Scheme (SST/050/20GP). We declare no competing interests.